April 2026 FDA Recall Drug by Island Kinetics, Inc. D.b.a. Covalence Laboratories
D-0487-2026 - Failed Stability Specifications

This Class II drug recall was voluntarily initiated by Island Kinetics, Inc. D.b.a. Covalence Laboratories on April 1, 2026 for the product Drug. The FDA reported the reason for recall as failed stability specifications. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0487-2026

Reason for Recall
Failed Stability Specifications
Initiated
04-01-2026
Reported
04-22-2026
Quantity
28,163 bottles

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
98705
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Island Kinetics, Inc. d.b.a. CoValence Laboratories
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
U.S. Nationwide
Product Description About Product Description
Full technical description of the product.
Blemish Spot Treatment (Salicylic Acid) 1%, .5 fl oz (15 ml) bottles, Skin Script, Chandler, AZ 85226, UPC 6 10563 13873 9.

Batch or Lot Expiration Information

Lot# : 4228D2, 4229D1, Exp.: 07/31/2026
Lot# : 5147D2, Exp.: 04/30/2027